SYRS

Syros Pharmaceuticals, Inc. SYRS

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode SYRS VCYT LGVN LYRA MCRB CGEN
6M -79.17 % 8.09 % -45.30 % 54.99 % 65.37 % 62.30 %
YTD -97.83 % -15.00 % -54.46 % -26.67 % 15.77 % 23.94 %
1Y -99.75 % 1.31 % -57.98 % -28.84 % 16.81 % 21.73 %
3Y -99.92 % 111.92 % -97.74 % -96.75 % -86.25 % 146.39 %
5Y -99.99 % -18.20 % -98.90 % -98.73 % -97.15 % -88.61 %
10Y -100.00 % 484.59 % -98.90 % -99.15 % -96.64 % -63.42 %
From the beginning -100.00 % 159.42 % -98.90 % -99.15 % -98.10 % -81.62 %

Dividend